1334 GMT - L'Oreal's move to double its stake in Galderma will increase the cosmetics company's earnings-per-share by 2%, analysts at J.P. Morgan write. The deal will also bring L'Oreal's debt-to-earnings ratio into the green. The deal leaves the door open for L'Oreal to further increase its stake in the Swiss dermatology group, the analysts say. However, the Paris-listed company said no such increases are planned. L'Oreal shares fall 2.4% to 363.90 euros. Galderma shares rise 2% to 166.10 Swiss francs. (josephmichael.stonor@wsj.com)
(END) Dow Jones Newswires
December 08, 2025 08:34 ET (13:34 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.